A Study of the Effects of Ketoconazole Taken Orally Has on the PK Profiles of a Dose of GSK189075 in Healthy Volunteers

NCT00501397 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Diabetes Mellitus, Type 2

Interventions

DRUG: ketoconazole
DRUG: GSK189075

Sponsor

GlaxoSmithKline